Cancer Vaccine Industry, March 2015 Market Reports from Top Publishers

You might be interested in: Vaccine, Drug, Oncology, Pharmaceutical, Therapeutics.


 
1-10 of 87 reports for Cancer Vaccine

Purchase Reports From Reputable Market Research Publishers

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach $4.3 billion in 2019, registering a compound ...

Global & USA Cancer Immunotherapy Market Analysis to 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, & Others

Global & USA Cancer Immunotherapy Market Analysis to 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, & Others

  • $ 3 500
  • Industry report
  • April 2015
  • by Kelly Scientific Publications

GLOBAL & USA CANCER IMMUNOTHERAPY MARKET ANALYSIS TO 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell ...

Cancer Vaccines Drug Pipeline Update 2015

Cancer Vaccines Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. However, despite years of R&D, a reproducible survival benefit has ...

Cancer Vaccine Partnering Terms and Agreements

Cancer Vaccine Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • December 2014
  • by Currentpartnering

The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. Trends ...

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

  • $ 2 495
  • Industry report
  • September 2014
  • by CHI Insight Pharma Reports

This report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy. Cancer immunotherapy was once just a dream in the minds of physicians, clinicians ...

Analytical Tool - Cancer Vaccines

Analytical Tool - Cancer Vaccines

  • $ 4 650
  • Industry report
  • March 2014
  • by Bioseeker

"Analytical Tool - Cancer Vaccines" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer vaccine drug development. It is at the same time a map of the ...

Competitor Analysis: Cancer Vaccines

Competitor Analysis: Cancer Vaccines

  • $ 1 056
  • Industry report
  • March 2014
  • by La Merie Publishing

Cancer Vaccines The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines to fight cancer as of ...

Triple Analysis: Lung Cancer, Melanoma and Cancer Vaccines

Triple Analysis: Lung Cancer, Melanoma and Cancer Vaccines

  • $ 5 175
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lung Cancer and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated ...

Triple Analysis: Lymphoma, Melanoma and Cancer Vaccines

Triple Analysis: Lymphoma, Melanoma and Cancer Vaccines

  • $ 5 175
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated ...

Triple Analysis: Leukemia, Melanoma and Cancer Vaccines

Triple Analysis: Leukemia, Melanoma and Cancer Vaccines

  • $ 5 175
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the mechanism/target/effect of Cancer Vaccines. Each of these three individual parts is evaluated ...

About 1 400 reports for Cancer Vaccine

Download Unlimited Documents from Trusted Public Sources

Vaccine Industry in the US

  • April 2014
    17 pages
  • Vaccine  

    Cancer  

  • United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.